Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes - Zinman, B; Wanner, C; Lachin, JM; Fitchett, D; Bluhmki, E; Hantel, S (N Engl J Med, 2015)
et al.